This preliminary pilot exploration aims at specifying the pharmacokinetic parameters of
sulthiame, formulated as an immediate release tablet, thus helping to design proper clinical
trials for the future assessment of new paediatric formulations currently under development.
The clinical tolerability to single doses of sulthiame will also be closely monitored to
orient future trials.